ARCHIVES

FDA, NCI, CMS Announce Biomarker Initiative; First Project To Validate FDG-PET As Predictor Of Tumor Response In Non-Hodgkin’s Lymphoma.

This article is from The Cancer Letter archive.

Vol. 32 No. 06 | February 17, 2006

Download PDF Visit The Full Archive

Related Articles

ACS President Lawrence Emphasizes Prevention Gains Since 1971

April 10, 1992

AIDS Patients Face Higher Risk Of HPV-Related Cancers As Immunosuppression Grows

August 28, 2009

Hybridoma Cell Lines Available from NCI

September 3, 1982

Updated EMILIA Phase III Trial Results Confirm Increase in Overall Survival

August 31, 2012

Plant-Based Diet Associated With Improved Survival

April 25, 2008

Aventis, MediGene In Pact For Development Of Vaccine.

February 25, 2000